Drug Profile
Research programme: stem cell therapies - Celogos
Alternative Names: AlloCell; Allogenic projectLatest Information Update: 24 Jul 2006
Price :
$50
*
At a glance
- Originator Celogos
- Class Stem cell therapies
- Mechanism of Action Stem cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders; Musculoskeletal disorders
Most Recent Events
- 24 Jul 2006 Preclinical trials in Cardiovascular disorders in France (Parenteral)
- 24 Jul 2006 Preclinical trials in Musculoskeletal disorders in France (Parenteral)